William C. Bertrand's Insider Trades & SAST Disclosures
William C. Bertrand's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 1,612,032 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William C. Bertrand.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 5,584 | 7,510 (0%) | 0% | 0.6 | 3,243 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 9,803 | 13,756 (0%) | 0% | 0.6 | 5,635 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 5,471 | 7,623 (0%) | 0% | 0.6 | 3,216 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 4,268 | 5,845 (0%) | 0% | 0.6 | 2,509 | American Depositary Shares representing Ordinary Shares |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 11,023 | 229,766 (0%) | 0% | 0 | Common Stock | |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 13,599 | 20,201 (0%) | 0% | 0.7 | 9,152 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 5,309 | 7,785 (0%) | 0% | 0.7 | 3,573 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 4,681 | 7,023 (0%) | 0% | 0.8 | 3,698 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 5,220 | 7,874 (0%) | 0% | 0.9 | 4,458 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | William C. Bertrand | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 4,009 | 6,104 (0%) | 0% | 0.8 | 3,354 | American Depositary Shares representing Ordinary Shares |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 49,237 | 49,237 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 16,581 | 218,743 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 118,613 | 202,162 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 32,765 | 32,765 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,891 | 83,549 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 7.08 per share. | 14 Dec 2020 | 15,000 | 74,658 (0%) | 0% | 7.1 | 106,256 | Common Stock |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | William C. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 7,523 | 59,658 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges